Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Neuphoria Therapeutics (NEUP) Shares Outstanding (Diluted Average) (2023 - 2025)

Historic Shares Outstanding (Diluted Average) for Neuphoria Therapeutics (NEUP) over the last 3 years, with Q4 2025 value amounting to $4.5 billion.

  • Neuphoria Therapeutics' Shares Outstanding (Diluted Average) rose 28787030.81% to $4.5 billion in Q4 2025 from the same period last year, while for Dec 2025 it was $4.5 billion, marking a year-over-year increase of 28787030.81%. This contributed to the annual value of $1.6 million for FY2025, which is N/A changed from last year.
  • According to the latest figures from Q4 2025, Neuphoria Therapeutics' Shares Outstanding (Diluted Average) is $4.5 billion, which was up 28787030.81% from $2.2 million recorded in Q3 2025.
  • In the past 5 years, Neuphoria Therapeutics' Shares Outstanding (Diluted Average) ranged from a high of $4.5 billion in Q4 2025 and a low of $1.3 million during Q3 2024
  • In the last 3 years, Neuphoria Therapeutics' Shares Outstanding (Diluted Average) had a median value of $1.7 million in 2025 and averaged $789.5 million.
  • Over the last 5 years, Neuphoria Therapeutics' Shares Outstanding (Diluted Average) had its largest YoY gain of 28787030.81% in 2025, and its largest YoY loss of 7276.57% in 2025.
  • Quarter analysis of 3 years shows Neuphoria Therapeutics' Shares Outstanding (Diluted Average) stood at $981.6 million in 2023, then tumbled by 99.84% to $1.6 million in 2024, then surged by 287870.31% to $4.5 billion in 2025.
  • Its last three reported values are $4.5 billion in Q4 2025, $2.2 million for Q3 2025, and $1.6 million during Q2 2025.